晚期癌症和自身免疫性疾病患者的免疫疗法利用模式
Huaqi Li1, Scott Huntington2,3, Cary Gross2,4
1Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, United States of America.
患有自身免疫性疾病 (AD) 的患者接受的癌症免疫疗法较少. 然而,接受治疗的人完成了类似数量的循环,这表明阿尔茨海默病不是免疫治疗的禁忌.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 免疫疗法显著改善了癌症的生存率.
- 缺乏关于免疫疗法在患有自身免疫性疾病 (AD) 的癌症患者使用的共识指南.
研究的目的:
- 检查AD和没有AD的癌症患者的免疫治疗利用模式.
- 为了在这些组之间比较一线,整体免疫疗法使用和循环计数.
主要方法:
- 追溯性队列研究,使用非识别的全国性瘤学数据库.
- 包括晚期黑色素瘤,非小细胞肺癌和细胞癌的患者.
- 后勤和Poisson回归模型分析了AD和免疫治疗利用之间的关联.
主要成果:
- 患有AD的患者 (796/25,076) 接受一线 (OR=0.68) 和整体免疫疗法 (OR=0.80) 的可能性较低.
- 在接受免疫治疗的患者中,周期的平均数量相似 (11.3为AD,10.5为非AD).
- 免疫治疗周期的发生率在阿尔茨海默病患者中略高 (IRR=1.03).
结论:
- 自免疫性疾病 (AD) 与接受先进癌症的第一线和整体免疫治疗的可能性降低有关.
- 对于开始免疫治疗的患者来说,AD似乎不会限制接受的循环数量.
- 临床实践表明,阿尔茨海默病并不是免疫治疗的绝对禁忌,这表明潜在的耐受性和益处.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Tumor Immunotherapy
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
